Capps Scott B 4
4 · CRYOLIFE INC · Filed Dec 16, 2020
Insider Transaction Report
Form 4
CRYOLIFE INCCRY
Capps Scott B
VP, Clinical Research
Transactions
- Exercise/Conversion
Common Stock
2020-12-15$9.97/sh+10,000$99,700→ 157,006 total - Sale
Common Stock
[F1]2020-12-15$21.34/sh−8,366$178,553→ 148,640 total - Exercise/Conversion
Stock Option (Right to Buy)
[F2]2020-12-15$9.97/sh−10,000$99,700→ 0 totalExercise: $9.97From: 2015-02-26Exp: 2021-02-26→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Reflects weighted average price. Range was from $21.25 to $21.45. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- [F2]Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/26/2015
Signature
/s/ Scott Capps|2020-12-16